| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851578 | American Heart Journal | 2009 | 8 Pages |
Abstract
We demonstrate that full-dose niacin/moderate-dose simvastatin combination has sustained benefits on atherogenic apoB lipoproteins, at least comparable to high-dose simvastatin, while also raising HDL-cholesterol. Results of large clinical trials will inform whether niacin-statin combinations reduce cardiovascular disease events.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Subha L. MD, Ronald L. MD, PhD, Megan L. BSc, Mahlet ScD, Emile MD, Muredach P. MB, MSCE,